Table 4. Differences in F2-isoprostane (pg/mL) serum levels between caloric restriction (CR) and control groups at baseline (Day 0), during the intervention (Days 1 to 29), and follow-up (Days 42 and 119).
Time | N | Control diet | CR diet | p-valuea |
Baseline | 40 | 61.0 (51.8–65.0) | 57.0 (40.5–79.5) | 0.908 |
Day 1 | 40 | 55.0 (48.8–65.0) | 44.0 (35.5–61.2) | 0.153 |
Day 3 | 40 | 56.0 (46.8–73.5) | 39.5 (24.8–50.2) | 0.010 |
Day 5 | 40 | 62.5 (45.0–72.5) | 33.5 (26.0–48.0) | 0.002 |
Day 7 | 40 | 52.0 (45.0–66.0) | 33.5 (23.8–45.8) | 0.007 |
Day 14 | 40 | 50.0 (42.0–67.5) | 34.0 (23.5–43.5) | 0.004 |
Day 21 | 40 | 58.0 (49.2–60.2) | 30.5 (23.8–42.5) | <0.001 |
Day 29 | 38 | 51.0 (49.2–53.5) | 29.5 (23.2–40.8) | <0.001 |
Day 42 | 37 | 61.0 (55.0–65.0) | 33.5 (29.0–53.5) | 0.006 |
Day 119 | 34 | 56.0 (52.0–59.5) | 56.0 (36.0–66.0) | 0.692 |
Data are presented as median (interquartile range- IQR). CR diet, caloric restriction diet.
Wilcoxon rank sum test for differences between Control and CR diets.